Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell therapies, with clinical programs in cardiovascular disease and immuno-oncology, today announced the appointment of Pierre Brynaert as Chief Human Resources Officer, effective January 4, 2016.

Pierre Brynaert currently serves as Human Resources Director EMEAI, LATAM & Asia Pacific for Volcano Corporation (part of Philips Healthcare IGT), a leading company active in Intravascular imaging for coronary and peripheral applications, and physiology.

Brynaert brings over 25 years of significant Human Resources Senior Leadership roles in the Healthcare Industry, both large multinational corporations and smaller entrepreneurial entities (Astra Zeneca; Novartis, EV3).

He holds a Master of Science in Applied Economy (ICHEC BRUSSELS, Belgium) as well as a Certified Teacher Degree. He also followed a Senior Executive MBA at IMD Lausanne, Switzerland.

Dr. Christian Homsy, CEO of Celyad: “We are pleased to welcome Pierre to our team. As a fast-growing company, Celyad is facing new human resources challenges.  We are currently employing 95 people and we keep on recruiting to support our expansion. Thanks to his Senior Leadership experience, Pierre will contribute to drive the evolution of our internal organization while ensuring the well-being of all our employees”.

Pierre Brynaert: “I am very excited to join Celyad at this moment and contribute to its growing success by building People and Organizational Capability to face coming Businesses Challenges. Since my very first contact with the Board and the Executive team I have been impressed by the high level of commitment to make Celyad a key contributor to address diseases with high unmet medical needs such as heart failure and cancer”.

Pierre Brynaert will be based in Mont-Saint-Guibert, Belgium and will report directly to Christian Homsy, Chief Executive Officer. 

Download press release(s)

Press release

299.17 Ko

Communiqué de presse

315.83 Ko

Persbericht

271.72 Ko

Celyad announces the publication of its CHART-1 trial design methods paper in the Europe...

Next News

Celyad announces the publication of its CHART-1 trial design methods paper in the Europe...